Jo A. Kelly

9 papers receiving 311 citations

Peers

Jo A. Kelly
Comparison fields: 5 of 39
  • Molecular Biology 185
  • Pulmonary and Respiratory Medicine 151
  • Genetics 114
  • Endocrinology, Diabetes and Metabolism 86
  • Pathology and Forensic Medicine 49
Replace Andrej Poleev with:
Andrej Poleev Germany
Serge Nolet Canada
Hagit Schayek Israel
Xueke You United States
Catarina Santos Portugal
Yourha Kim South Korea
Cai Lv China
Ana Clode Portugal
Iikki Donner Finland
Anne‐Sophie Chong Canada
Jo A. Kelly relative to Andrej Poleev Germany Andrej Poleev's profile →
Citations per field
00.5×3.1×
Andrej Poleev · 1×
Citations per year

Countries citing papers authored by Jo A. Kelly

Since Specialization
Citations

This map shows the geographic impact of Jo A. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo A. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo A. Kelly more than expected).

Fields of papers citing papers by Jo A. Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo A. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo A. Kelly. The network helps show where Jo A. Kelly may publish in the future.

Co-authorship network of co-authors of Jo A. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Jo A. Kelly. A scholar is included among the top collaborators of Jo A. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo A. Kelly. Jo A. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 15
2
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
90
3 17
4 121
5 26
6 21
7 9
8 18
9 6

About Jo A. Kelly

Jo A. Kelly is a scholar working on Pathology and Forensic Medicine, Oral Surgery and Cancer Research, having authored 9 papers that have together received 323 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (4 papers), BRCA gene mutations in cancer (3 papers) and Head and Neck Surgical Oncology (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (86 citations), Pulmonary and Respiratory Medicine (151 citations) and Genetics (114 citations). Jo A. Kelly has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Audrey Ardern‐Jones, Rosalind A. Eeles, Anna Dowe, Robert Shearer, Stephen M. Edwards, Grady F. Saunders, Simon A. Osborne, Ralph Minter, Nadine Collins and David P. Dearnaley. Their work appears in journals such as The Journal of Physiology, American Journal of Epidemiology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026